Director Pax Margaret bought 250 RGEN shares at $150.69; holdings now 1,043 shares (+31.5%)
Pax Margaret (Director) purchased 250 shares at $150.69 on 2025-03-17, increasing her position by 31.5% to 1,043 total shares. The transaction occurred when the stock was trading 27.7% below its 52-week high of $199.74, having declined 1.8% over the prior 30 days. However, context tempers any interpretation: REPLIGEN's most recent fiscal year ended with negative net income (full-year net income was negative), and the company reported a net loss of $-654.0K in its latest quarter against revenue of $154.9M, suggesting operational strain. Annual revenue growth was flat at -0.7% versus the prior year. Without FLAGS or TRACK RECORD data indicating this purchase was pre-scheduled, the buy at a price materially below the 52-week high occurs at a moment when the company's profitability picture remains challenged.